Unternehmen
Merck & Co., Inc

Aktueller Kurs
83.38 USD

Symbol
MRK

ISIN
DE0006599905

Börse
NYSE

Sektor
Health Care

Marktkapitalisierung
210.954 Mrd. US

Branche
Pharmaceuticals

Dividendenrendite
3.12 %

Ausschüttungsquote
42.98 %

KGV
18.41

KUV (TTM)
4.46

KGVe
12.67

Kursziel
96.58 USD

Unternehmen
Merck & Co., Inc

Aktueller Kurs
83.38 USD

Symbol
MRK

ISIN
DE0006599905

Börse
NYSE

Marktkapitalisierung
210.954 Mrd. USD

Sektor
Health Care

Branche
Pharmaceuticals

Dividendenrendite
3.12 %

Ausschüttungsquote
42.98 %

KGV
18.41

KUV (TTM)
4.46

KGVe
12.67

Kursziel
96.58 USD

Live-Chart (verzögert)

Firmenbeschreibung

Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; Intec Pharma Ltd.; Transcenta Holding Ltd.; and Janux Therapeutics, Inc. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Merck & Co., Inc Fundamentaldaten

Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)

Das Geschäftsjahr von Merck & Co., Inc endet im Dezember.

Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 3.219 3.002 2.941 0.000 9.162
2019 2.915 2.670 1.901 2.357 9.843
2018 0.736 1.707 1.950 1.827 6.220
2017 1.551 1.946 -0.056 -1.047 2.394
2016 1.125 1.205 2.184 -0.594 3.920
2015 0.953 0.687 1.826 0.976 4.442
2014 1.705 2.004 0.895 7.316 11.920
2013 1.593 0.906 1.124 0.781 4.404
2012 1.738 1.793 1.729 0.908 6.168
2011 1.043 2.024 1.692 1.513 6.272
2010 0.299 0.752 0.342 -0.532 0.861

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 1.5 1.37 1.74 0 4.61
2019 1.22 1.3 1.51 1.16 5.19
2018 1.05 1.06 1.19 1.04 4.34
2017 0.88 1.01 1.11 0.98 3.98
2016 0.89 0.93 1.07 0.89 3.78
2015 0.85 0.86 0.96 0.93 3.6
2014 0.88 0.85 0.9 0.87 3.5
2013 0.85 0.84 0.92 0.88 3.49
2012 0.5647 1.05 0.95 0.83 3.3947
2011 0.92 0.95 0.94 0.97 3.78
2010 0.83 0.86 0.85 0.88 3.42

Umsatz pro Jahr & Quartal in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 12.057 10.872 12.551 0 35.48
2019 10.816 11.76 12.397 11.868 46.841
2018 10.037 10.465 10.794 10.998 42.294
2017 9.434 9.93 10.325 10.433 40.122
2016 9.312 9.844 10.536 10.115 39.807
2015 9.425 9.785 10.073 10.215 39.498
2014 10.264 10.934 10.557 10.482 42.237
2013 10.671 11.01 11.032 11.32 44.033
2012 11.731 12.311 11.488 11.737 47.267
2011 11.58 12.151 12.022 12.294 48.047
2010 11.4222 11.3463 11.1249 12.0936 45.987

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 4.73 4.29 4.95 0.00 4.62
2019 4.16 4.54 4.82 4.60 18.16
2018 3.70 3.88 4.03 4.11 15.79
2017 3.41 3.61 3.79 3.80 14.60
2016 3.33 3.53 3.78 3.63 14.28
2015 3.29 3.43 3.55 3.60 13.90
2014 3.45 3.71 3.63 3.58 14.43
2013 3.50 3.66 3.73 3.78 14.70
2012 3.82 4.01 3.73 3.82 15.37
2011 3.73 3.91 3.89 3.97 15.53
2010 3.64 3.63 3.59 3.88 14.74

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 36.57 -6.74 -2.03 -100.00 -6.92
2019 59.55 -8.40 -28.80 23.99 58.25
2018 0.00 131.93 14.24 -6.31 159.82
2017 0.00 25.47 -102.88 0.00 -38.93
2016 15.27 7.11 81.24 -127.20 -11.75
2015 -86.97 -27.91 165.79 -46.55 -62.73
2014 118.31 17.54 -55.34 717.43 170.66
2013 75.44 -43.13 24.06 -30.52 -28.60
2012 14.87 3.16 -3.57 -47.48 -1.66
2011 0.00 94.06 -16.40 -10.58 628.46
2010 -95.40 151.81 -54.60 -255.68 -90.55

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 1.59 -9.83 15.44 0.00 0.00
2019 -1.65 8.73 5.42 -4.27 10.75
2018 -3.80 4.26 3.14 1.89 5.41
2017 -6.73 5.26 3.98 1.05 0.79
2016 -8.84 5.71 7.03 -4.00 0.78
2015 -10.08 3.82 2.94 1.41 -6.48
2014 -9.33 6.53 -3.45 -0.71 -4.08
2013 -9.08 3.18 0.20 2.61 -6.84
2012 -4.58 4.94 -6.69 2.17 -1.62
2011 -4.25 4.93 -1.06 2.26 4.48
2010 13.16 -0.66 -1.95 8.71 86.75

Merck & Co., Inc Fundamentaldaten

Gewinn pro Jahr & Quartal (Net Income)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 3.219 3.002 2.941 0.000 9.162
2019 2.915 2.670 1.901 2.357 9.843
2018 0.736 1.707 1.950 1.827 6.220
2017 1.551 1.946 -0.056 -1.047 2.394
2016 1.125 1.205 2.184 -0.594 3.920
2015 0.953 0.687 1.826 0.976 4.442
2014 1.705 2.004 0.895 7.316 11.920
2013 1.593 0.906 1.124 0.781 4.404
2012 1.738 1.793 1.729 0.908 6.168
2011 1.043 2.024 1.692 1.513 6.272
2010 0.299 0.752 0.342 -0.532 0.861

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 1.5 1.37 1.74 0 4.61
2019 1.22 1.3 1.51 1.16 5.19
2018 1.05 1.06 1.19 1.04 4.34
2017 0.88 1.01 1.11 0.98 3.98
2016 0.89 0.93 1.07 0.89 3.78
2015 0.85 0.86 0.96 0.93 3.6
2014 0.88 0.85 0.9 0.87 3.5
2013 0.85 0.84 0.92 0.88 3.49
2012 0.5647 1.05 0.95 0.83 3.3947
2011 0.92 0.95 0.94 0.97 3.78
2010 0.83 0.86 0.85 0.88 3.42

Umsatz pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 12.057 10.872 12.551 0 35.48
2019 10.816 11.76 12.397 11.868 46.841
2018 10.037 10.465 10.794 10.998 42.294
2017 9.434 9.93 10.325 10.433 40.122
2016 9.312 9.844 10.536 10.115 39.807
2015 9.425 9.785 10.073 10.215 39.498
2014 10.264 10.934 10.557 10.482 42.237
2013 10.671 11.01 11.032 11.32 44.033
2012 11.731 12.311 11.488 11.737 47.267
2011 11.58 12.151 12.022 12.294 48.047
2010 11.4222 11.3463 11.1249 12.0936 45.987

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 4.73 4.29 4.95 0.00 4.62
2019 4.16 4.54 4.82 4.60 18.16
2018 3.70 3.88 4.03 4.11 15.79
2017 3.41 3.61 3.79 3.80 14.60
2016 3.33 3.53 3.78 3.63 14.28
2015 3.29 3.43 3.55 3.60 13.90
2014 3.45 3.71 3.63 3.58 14.43
2013 3.50 3.66 3.73 3.78 14.70
2012 3.82 4.01 3.73 3.82 15.37
2011 3.73 3.91 3.89 3.97 15.53
2010 3.64 3.63 3.59 3.88 14.74

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 36.57 -6.74 -2.03 -100.00 -6.92
2019 59.55 -8.40 -28.80 23.99 58.25
2018 0.00 131.93 14.24 -6.31 159.82
2017 0.00 25.47 -102.88 0.00 -38.93
2016 15.27 7.11 81.24 -127.20 -11.75
2015 -86.97 -27.91 165.79 -46.55 -62.73
2014 118.31 17.54 -55.34 717.43 170.66
2013 75.44 -43.13 24.06 -30.52 -28.60
2012 14.87 3.16 -3.57 -47.48 -1.66
2011 0.00 94.06 -16.40 -10.58 628.46
2010 -95.40 151.81 -54.60 -255.68 -90.55

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 1.59 -9.83 15.44 0.00 0.00
2019 -1.65 8.73 5.42 -4.27 10.75
2018 -3.80 4.26 3.14 1.89 5.41
2017 -6.73 5.26 3.98 1.05 0.79
2016 -8.84 5.71 7.03 -4.00 0.78
2015 -10.08 3.82 2.94 1.41 -6.48
2014 -9.33 6.53 -3.45 -0.71 -4.08
2013 -9.08 3.18 0.20 2.61 -6.84
2012 -4.58 4.94 -6.69 2.17 -1.62
2011 -4.25 4.93 -1.06 2.26 4.48
2010 13.16 -0.66 -1.95 8.71 86.75

Merck & Co., Inc Dividenden-Entwicklung

Ex-Tag Record Date Zahltag Dividende
2020-12-14 2020-12-15 2021-01-08 0.65
2020-09-14 2020-09-15 2020-10-07 0.61
2020-06-12 2020-06-15 2020-07-07 0.61
2020-03-13 2020-03-16 2020-04-07 0.61
2019-12-13 2019-12-16 2020-01-08 0.61
2019-09-13 2019-09-16 2019-10-07 0.55
2019-06-14 2019-06-17 2019-07-08 0.55
2019-03-14 2019-03-15 2019-04-05 0.55
2018-12-14 2018-12-17 2019-01-08 0.55
2018-09-14 2018-09-17 2018-10-05 0.48
2018-06-14 2018-06-15 2018-07-09 0.48
2018-03-14 2018-03-15 2018-04-06 0.48
2017-12-14 2017-12-15 2018-01-08 0.48
2017-09-14 2017-09-15 2017-10-06 0.47
2017-06-13 2017-06-15 2017-07-10 0.47
2017-03-13 2017-03-15 2017-04-07 0.47
2016-12-13 2016-12-15 2017-01-09 0.47
2016-09-13 2016-09-15 2016-10-07 0.46
2016-06-13 2016-06-15 2016-07-08 0.46
2016-03-11 2016-03-15 2016-04-07 0.46